The relationship of drug treatment safety parameters and adherence to pharmacotherapy in patients with cardiovascular diseases (according to the data of the outpatient registry)

11 April 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Yulia Lukina

National Medical Research Center for Preventive Medicine, Moscow (Russian Federation)

13 More presentations in this session

Presentation thumbnail

Prognostic impact of proton pump inhibitors in patients after elective percutaneous coronary intervention with implantation of second-generation drug eluting stents

Doctor O. Shahmatova (Moscow, RU)

Presentation thumbnail

A novel direct method to evaluate adherence to atorvastatin therapy in coronary prevention - Cut-off values generated in a clinical non-adherence study

Doctor O. Kristiansen (Drammen, NO)

Presentation thumbnail

Focus-group as a qualitative method for study of compliance in cardiovascular disease patients and their doctors

Doctor O. Semenova (Saratov, RU)

Presentation thumbnail

Adherence to long-term treatment and some traits of patients and their doctors: a prospective study of treatment compliance in patients with cardiovascular diseases

Doctor Y. Bulaeva (Saratov, RU)

Presentation thumbnail

The impact of anaemia and intravenous iron replacement therapy on exercise capacity in patients after cardiac surgery.

Doctor C. Nugara (Palermo, IT)

Access the full session

Session thumbnail

Poster Session 1 - Cardiovascular Pharmacotherapy

The Event

EuroPrevent 2019

11 April - 13 April 2019

You may be interested in

Congress Presentation

State-of-the-art lecture on pharmacotherapy for acute coronary syndromes

Webinar

Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients

Congress Presentation

Addressing non-traditional cardiovascular risk factors - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources